Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →🤖 ML Fraud Detection Score: 93%
Machine learning model identifies prescribing patterns consistent with confirmed fraud cases. This is a statistical indicator, not an accusation.
Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
20,119
Total Claims
$1.2M
Drug Cost
481
Beneficiaries
$2,577
Cost/Patient
Risk Score Breakdown 26/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
+68%
Opioid rate vs peers
4.3% vs 2.6% avg
+141%
Cost per patient vs peers
$2,577 vs $1,068 avg
-3%
Brand preference vs peers
8.8% vs 9.0% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
4.3%
Opioid Rate
872
Opioid Claims
$13K
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,747 claims · $942K
Generic: 18,218 claims · $285K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Sitagliptin Phosphate | 88 | $61K |
| Liraglutide | 36 | $43K |
| Semaglutide | 37 | $43K |
| Semaglutide | 33 | $40K |
| Insulin Aspart | 14 | $38K |
| Insulin Detemir | 50 | $38K |
| Dulaglutide | 32 | $37K |
| Apixaban | 92 | $34K |
| Insulin Glargine,hum.Rec.Anlog | 52 | $34K |
| Fluticasone/Umeclidin/Vilanter | 37 | $29K |
| Dapagliflozin Propanediol | 36 | $26K |
| Evolocumab | 27 | $23K |
| Rivaroxaban | 38 | $22K |
| Linagliptin | 28 | $20K |
| Linaclotide | 35 | $20K |
Prescribing Profile
Patient Profile
72
Avg Age
59%
Female
1.14
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About